Hanne Merritt

1.1k total citations
13 papers, 532 citations indexed

About

Hanne Merritt is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Hanne Merritt has authored 13 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Hanne Merritt's work include Melanoma and MAPK Pathways (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Hanne Merritt is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Hanne Merritt collaborates with scholars based in United States, Switzerland and China. Hanne Merritt's co-authors include Michael T. Yim, Robert Schier, Keith W. Marshall, Adrian M. McCall, Gregory P. Adams, Cara Marks, James D. Marks, Robert S. Crawford, Louis M. Weiner and Darrin D. Stuart and has published in prestigious journals such as Journal of Molecular Biology, Cancer Cell and Cancer Research.

In The Last Decade

Hanne Merritt

13 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hanne Merritt United States	8	418	255	135	63	43	13	532
Hanna Björkelund Sweden	12	259 0.6×	204 0.8×	170 1.3×	83 1.3×	23 0.5×	21	464
David Coomber Singapore	15	536 1.3×	201 0.8×	296 2.2×	107 1.7×	17 0.4×	21	728
Caroline Ekblad Sweden	12	329 0.8×	308 1.2×	178 1.3×	87 1.4×	12 0.3×	13	563
Anca Clabbers United States	7	269 0.6×	271 1.1×	100 0.7×	112 1.8×	25 0.6×	9	402
Roberto Bitton United States	9	427 1.0×	96 0.4×	107 0.8×	235 3.7×	46 1.1×	10	556
Niranjan B. Pandey United States	17	956 2.3×	66 0.3×	115 0.9×	67 1.1×	125 2.9×	23	1.2k
Max Henderson United States	6	318 0.8×	60 0.2×	73 0.5×	28 0.4×	70 1.6×	9	476
Christine Dureuil France	7	344 0.8×	41 0.2×	170 1.3×	84 1.3×	29 0.7×	7	630
Barbara J.M. Booth United States	14	437 1.0×	610 2.4×	202 1.5×	126 2.0×	20 0.5×	21	788
Guanxin Shen China	13	411 1.0×	52 0.2×	62 0.5×	61 1.0×	26 0.6×	34	500

Countries citing papers authored by Hanne Merritt

Since Specialization

Citations

This map shows the geographic impact of Hanne Merritt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanne Merritt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanne Merritt more than expected).

Fields of papers citing papers by Hanne Merritt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanne Merritt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanne Merritt. The network helps show where Hanne Merritt may publish in the future.

Co-authorship network of co-authors of Hanne Merritt

This figure shows the co-authorship network connecting the top 25 collaborators of Hanne Merritt. A scholar is included among the top collaborators of Hanne Merritt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanne Merritt. Hanne Merritt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

MacDougall, John R., Mengqi Zhong, Hanne Merritt, et al.. (2023). Abstract 4945: Inhibition of wild-type PI3Kα signaling is required for durable efficacy in PI3Kα mutant cancer cells due to robust re-activation of wild-type PI3Kα signaling. Cancer Research. 83(7_Supplement). 4945–4945. 1 indexed citations

Liu, Yuxi, Hanne Merritt, Eileen Ambing, et al.. (2022). The structural mechanism of human glycogen synthesis by the GYS1-GYG1 complex. Cell Reports. 40(1). 111041–111041. 13 indexed citations

Merritt, Hanne, Tarunmeet Gujral, Terrence F. Satterfield, et al.. (2022). In-vitro characterization of MZE001, an orally active GYS1 inhibitor to treat Pompe disease. Molecular Genetics and Metabolism. 135(2). S32–S32. 3 indexed citations

Smith, Aaron, Zhi‐Jie Ni, Daniel Poon, et al.. (2017). Imidazo[1,2-a]pyridin-6-yl-benzamide analogs as potent RAF inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(23). 5221–5224. 8 indexed citations

Han, Wooseok, Daniel L. Menezes, Yongjin Xu, et al.. (2016). Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model. Bioorganic & Medicinal Chemistry Letters. 26(3). 742–746. 20 indexed citations

Yan, Kelly, Hanne Merritt, Kenneth Crawford, et al.. (2015). Expression, purification and characterization of inactive and active forms of ERK2 from insect expression system. Protein Expression and Purification. 110. 172–179. 1 indexed citations

Pecchi, Sabina, Zhi‐Jie Ni, Wooseok Han, et al.. (2013). Structure guided optimization of a fragment hit to imidazopyridine inhibitors of PI3K. Bioorganic & Medicinal Chemistry Letters. 23(16). 4652–4656. 6 indexed citations

Holderfield, Matthew, Hanne Merritt, John S.D. Chan, et al.. (2013). RAF Inhibitors Activate the MAPK Pathway by Relieving Inhibitory Autophosphorylation. Cancer Cell. 23(5). 594–602. 96 indexed citations

Stuart, Darrin D., Nanxin Li, Daniel J. Poon, et al.. (2012). Abstract 3790: Preclinical profile of LGX818: A potent and selective RAF kinase inhibitor. Cancer Research. 72(8_Supplement). 3790–3790. 41 indexed citations

10.

Pecchi, Sabina, Paul A. Renhowe, Clarke Taylor, et al.. (2010). Identification and structure–activity relationship of 2-morpholino 6-(3-hydroxyphenyl) pyrimidines, a class of potent and selective PI3 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(23). 6895–6898. 24 indexed citations

11.

Nagel, Tobi, Kevin Shoemaker, Nanxin Li, et al.. (2010). Abstract 20: Raf kinase inhibitors can induce Raf dimerization, downstream signaling, and cell growth. Cancer Research. 70(8_Supplement). 20–20. 2 indexed citations

12.

Merritt, Hanne, Andrew J. McCullough, & Mary A. Schuler. (1997). Internal AU‐rich elements modulate activity of two competing 3′ splice sites in plant nuclei. The Plant Journal. 12(4). 937–943. 13 indexed citations

13.

Schier, Robert, Adrian M. McCall, Gregory P. Adams, et al.. (1996). Isolation of Picomolar Affinity Anti-c-erbB-2 Single-chain Fv by Molecular Evolution of the Complementarity Determining Regions in the Center of the Antibody Binding Site. Journal of Molecular Biology. 263(4). 551–567. 304 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact